register

Marketing & Strategy

PRIME Award winners announced; AstraZeneca tops the list

Health Industry Hub | September 27, 2019 |

This year, the 15th annual PRIME Awards captured some of the best and the brightest in the pharmaceutical and media industries come together to celebrate their achievements in healthcare communications.

Diligence, creativity and innovation paid off for a record number of finalists who walked the red carpet on Thursday night at Sydney’s Four Season’s Hotel.

Hosted by multi award winning comedian Urzila Carlson, the evening kicked off with some fun and frivolity before taking a different tack with an opening address by Elizabeth de Somer, CEO of Medicines Australia, on progress in the pharmaceutical industry.

AstraZeneca was the biggest winner on the night, scoring the top spot across three major categories.

A productive partnership with McCann Health resulted in the pharma giant nabbing the Creativity in Communication – Prescription award for Zoladex’s “Great Wall of Undies” campaign from five nominations.

Health Industry Hub offers a wealth of content in a one-stop-hub to engage Pharma, MedTech and Biotech industry professionals. Enhance visibility and amplify your brand value to our subscribers. Contact us.

AstraZeneca also took home the award for Best PR Campaign and won the top spot in a new category, Sustained Excellence in Bettering Patient Outcomes which recognised the Lung Foundation’s enduring campaign by LIFE agency.

Hot on AstraZeneca’s heels was Gilead, who in collaboration with Ward6 won two awards including the coveted Marketing Campaign of the Year gong.

Other pharma companies who dominated the proceedings were Mylan who scooped up two major awards, along with Servier, Otsuka, Amgen, Sequirus, Bristol-Myers Squib and Biogen who each won first place in one of the 17 categories.

You may also like Assessing clinician and patient motivation


News & Trends - MedTech & Diagnostics

APAC medtech company scores TGA approval in heart disease

APAC medtech company scores TGA approval in heart disease

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]

More


News & Trends - MedTech & Diagnostics

New state-based pilot to back home-grown medtech innovation

New state-based pilot to back home-grown medtech innovation

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]

More


News & Trends - Pharmaceuticals

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Health Industry Hub | October 4, 2024 |

Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]

More


News & Trends - Pharmaceuticals

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Health Industry Hub | October 4, 2024 |

Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]

More


This content is copyright protected. Please subscribe to gain access.